Healing and Improving Postnatal Nights Through Sleep (HIPNoS)
Key facts
- Who runs it
- Henry Ford Health System
- Where
- Novi, United StatesSee the site
- Trial code
- Status
- Not yet recruiting
- People taking part
- 60 people, planned
- Starts
- 3 Jan 2027
- Expected to end
- 1 Oct 2029
- Type of study
- Interventional, 2 groups
- Treatments tested
- Perinatal Understanding of Mindful Awareness for Sleep (PUMAS)
- Sleep Hygiene Education (SHE)
- Record updated
- 17 November 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women only
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Participant is willing and able to give informed consent for participation in the trial
- Participant must be able to engage in treatment (e.g., has internet access to attend telemedicine appointments or access online sleep hygiene materials)
- Aged 18 years or above
- Postpartum 4-12 months at time of screening
- Meets diagnostic criteria for DSM-5 insomnia disorder, acute (symptoms lasting ≥1 month)
- Clinically severe insomnia symptom severity (Insomnia Severity Index score ≥11)
- Clinically significant depression symptoms (Edinburg Postnatal Depression Scale score ≥10)
Who cannot take part
- Current engagement in psychotherapy for insomnia disorder (current use of sleep aids [prescription, over-the-counter, or dietary supplements] is NOT exclusionary)
- Sleep complaints primarily due to infant sleep problems as ascertained via clinical interview and/or describing the infant's sleep as a 'moderate' or 'serious' problem on the Brief Infant Sleep Questionnaire on the screening survey
- Suicidal intent per the Columbus Suicide Severity Rating Scale (Suicidal ideation WITHOUT intent is NOT exclusionary)
- Night or rotating shift work
- Unreliable internet access that prevents a patient from being to engage with treatment and/or assessments
Where in United States
- Henry Ford Medical Center-ColumbusNovi, United StatesContact: Heba Research Operations ManagerNot yet recruiting
About the trial
What the trial wants to find out
Insomnia and depression are highly prevalent during postpartum, but effective treatment options are severely limited. Perinatal Understanding of Mindful Awareness (PUMAS) combines behavioral sleep strategies and mindfulness-based exercises to improve sleep and mood during pregnancy. Indeed, PUMAS has been shown to effectively treatment comorbid insomnia and depression in pregnancy in controlled and uncontrolled trials. The present randomized controlled trial (RCT) will evaluate the effectiveness of PUMAS in a sample of postpartum women with comorbid insomnia and depression who will be randomized to to telemedicine PUMAS or online sleep hygiene education (SHE; enhanced usual care). Patients will be treated for six weeks followed by assessment after treatment then follow-up assessment 3-months later. The investigators hypothesize that PUMAS patients, relative to SHE patients, will report superior acute treatment effects on insomnia and depression as well as more durable effects at 3-month follow-up.
The 2 groups in the trial
- Perinatal Understanding of Mindful Awareness for Sleep (PUMAS)Treatment being tested
Participants assigned to receive the PUMAS intervention.
- Sleep hygiene education (SHE)Other group
Participants assigned to receive six weeks of educational materials as an enhanced usual-care control.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Healing and Improving Postnatal Nights Through Sleep (HIPNoS): A Randomized Controlled Trial Evaluating Perinatal Understanding of Mindful Awareness for Sleep (PUMAS) in Postpartum Women With Insomnia and Depression.
- Record updated
- 17 November 2026